Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between Risk Scores for Genetic Variants and Percentage of Time in Therapeutic Range for Participants With Atrial Fibrillation, Deep Vein Thrombosis, and/or Intracardiac Thrombosis Taking Warfarin

NCT03894878 is registered in ClinicalTrials.gov with Cipherome, Inc. as lead sponsor.

NCT NCT03894878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between Risk Scores for Genetic Variants and Percentage of Time in Therapeutic Range for Participants With Atrial Fibrillation, Deep Vein Thrombosis, and/or Intracardiac Thrombosis Taking Warfarin
Lead sponsor
Cipherome, Inc.
Phase
Observational
Overall status
Completed
Start date
February 11, 2019
Completion date
September 30, 2022
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, deep vein thrombosis, intracardiac thrombus, pulmonary embolism, venous thromboembolic disease